Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Reconstitution Testing of Lyophilized Products

Posted on By

SOP for Reconstitution Testing of Lyophilized Products

Standard Operating Procedure for Reconstitution Testing of Lyophilized Products

1) Purpose

This SOP describes the steps to be taken during the reconstitution testing of lyophilized products to verify that the product dissolves as expected and retains its potency and stability after reconstitution.

2) Scope

This SOP applies to all laboratory personnel responsible for reconstituting lyophilized products and ensuring product quality post-reconstitution.

3) Responsibilities

  • Laboratory Personnel: Responsible for conducting the reconstitution testing according to the Batch Manufacturing Record (BMR).
  • QA Personnel: Responsible for verifying that reconstitution results meet product specifications.
See also  SOP for Incorporation of Stabilizers in Lyophilized Formulations

4) Procedure

4.1 Reconstitution Process

4.1.1 Diluent Selection

  • 4.1.1.1 Use the appropriate diluent as specified in the BMR for reconstituting the lyophilized product.
  • 4.1.1.2 Add the diluent to the vial containing the lyophilized product and gently swirl to dissolve. Do not shake vigorously to avoid foaming or denaturation.

4.1.2 Time to Dissolve

  • 4.1.2.1 Record the time it takes for the product to fully dissolve. The dissolution time must be within the limits defined in the BMR.

4.1.3 Clarity Testing

  • 4.1.3.1 After reconstitution, inspect the solution for clarity. The solution must be clear and free of particulates unless otherwise specified in the product’s standards.
See also  SOP for Mixing and Homogenization Techniques in Lyophilized Formulations

4.2 Documentation

All results from reconstitution testing, including dissolution time and clarity, must be documented in

the Reconstitution Testing Logbook. Ensure QA reviews the results before approving the batch for release.

5) Abbreviations

  • BMR: Batch Manufacturing Record

6) Documents

  • Reconstitution Testing Logbook

7) References

  • Pharmacopoeial guidelines for reconstitution testing of lyophilized products

8) SOP Version

Version 1.1

Annexure

Reconstitution Testing Logbook Template

Date Product Name Batch No. Reconstitution Time Clarity Test Operator Initials QA Verification
DD/MM/YYYY Product Name Batch Number Minutes Pass/Fail Operator Name QA Initials


Lyophilized Products Tags:Aseptic lyophilization process SOP, FDA guidelines for lyophilized products, Freeze-drying cycle development SOP, Lyophilized product SOP, Lyophilizer calibration SOP, Moisture content testing in lyophilized products, Pharmaceutical freeze-drying SOP, Quality control SOP for lyophilized drugs, SOP for cryoprotectants in lyophilized formulations, SOP for freeze-dried formulation optimization, SOP for handling lyophilized products, SOP for lyophilization of injectable drugs, SOP for lyophilization process in pharmaceuticals, SOP for lyophilization process validation, SOP for lyophilized antibiotics production, SOP for lyophilized product packaging, SOP for lyophilized product storage, SOP for lyophilized product vial filling, SOP for lyophilized vaccine production, SOP for lyophilizer equipment maintenance, SOP for pharmaceutical freeze-drying validation, SOP for primary drying in lyophilization, SOP for reconstitution of lyophilized drugs, SOP for secondary drying in lyophilization, SOP for stability testing of lyophilized products

Post navigation

Previous Post: SOP for Spill Management and Containment of Nanoparticles
Next Post: SOP for Incorporating APIs in Emulsion Formulations

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version